EurekaMag.com logo
+ Site Statistics
References:
53,869,633
Abstracts:
29,686,251
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on LinkedInFollow on LinkedIn

+ Translate

Clinical and preclinical translation of cell-based therapies using adipose tissue-derived cells



Clinical and preclinical translation of cell-based therapies using adipose tissue-derived cells



Stem Cell Research & Therapy 1(2): 19-19



Adipose tissue is now recognized as an accessible, abundant, and reliable site for the isolation of adult stem cells suitable for tissue engineering and regenerative medicine applications. The past decade has witnessed an explosion of preclinical data relating to the isolation, characterization, cryopreservation, differentiation, and transplantation of freshly isolated stromal vascular fraction cells and adherent, culture-expanded, adipose-derived stromal/stem cells in vitro and in animal models. This body of work has provided evidence supporting clinical translational applications of adipose-derived cells in safety and efficacy trials. The present article reviews the case reports and phase I-III clinical evidence using autologous adipose-derived cells that have been published, to date, in the fields of gastroenterology, neurology, orthopedics, reconstructive surgery, and related clinical disciplines. Future directions and challenges facing the field are discussed and evaluated.

(PDF emailed within 0-6 h: $19.90)

Accession: 052107880

Download citation: RISBibTeXText

PMID: 20587076

DOI: 10.1186/scrt19



Related references

Concise review: adipose tissue-derived stromal cells--basic and clinical implications for novel cell-based therapies. Stem Cells 25(4): 818-827, 2007

Effect of tissue-harvesting site on yield of stem cells derived from adipose tissue: implications for cell-based therapies. Cell and Tissue Research 332(3): 415-426, 2008

Bone differentiation and formation using adipose tissue-derived stromal cells for cell-based therapies. Boei Ika Daigakko Zasshi 32(4): 186-197, 2007

Adipose-derived stem and stromal cells for cell-based therapy: current status of preclinical studies and clinical trials. Current Opinion in Molecular Therapeutics 12(4): 442-449, 2010

Adipose-derived stromal vascular fraction cells and platelet-rich plasma: basic and clinical evaluation for cell-based therapies in patients with scars on the face. Journal of Craniofacial Surgery 25(1): 267-272, 2015

Adipose-Derived Stem Cells as a Tool in Cell-Based Therapies. Archivum Immunologiae et Therapiae Experimentalis 64(6): 443-454, 2016

Clinical translation of microbe-based therapies: Current clinical landscape and preclinical outlook. Bioengineering & Translational Medicine 3(2): 124-137, 2018

Porcine adipose-derived stem cells from buccal fat pad and subcutaneous adipose tissue for future preclinical studies in oral surgery. Stem Cell Research & Therapy 4(6): 148-148, 2014

Human adipose-derived stromal cells for cell-based therapies in the treatment of systemic sclerosis. Cell Transplantation 22(5): 779-795, 2013

Preclinical Biosafety Evaluation of Genetically Modified Human Adipose Tissue-Derived Mesenchymal Stem Cells for Clinical Applications to Brainstem Glioma. Stem Cells and Development 25(12): 897-908, 2016

Multilineage cells from human adipose tissue: implications for cell-based therapies. Tissue Engineering 7(2): 211-228, 2001

Reduction of N-glycolylneuraminic acid xenoantigen on human adipose tissue-derived stromal cells/mesenchymal stem cells leads to safer and more useful cell sources for various stem cell therapies. Tissue Engineering. Part A 16(4): 1143-1155, 2010

Concise review: mind the gap: challenges in characterizing and quantifying cell- and tissue-based therapies for clinical translation. Stem Cells 28(5): 996-1004, 2010

Adipose-Derived Stromal Vascular Fraction Cells and Platelet-Rich Plasma: Basic and Clinical Implications for Tissue Engineering Therapies in Regenerative Surgery. Methods in Molecular Biology 1773: 107-122, 2018

Concise review: adipose-derived stromal vascular fraction cells and platelet-rich plasma: basic and clinical implications for tissue engineering therapies in regenerative surgery. Stem Cells Translational Medicine 1(3): 230-236, 2013